Primary tabs
The list of publications is indicative and may not include all publications.
Tenofovir alafenamide prophylaxis post-liver transplantation: a real-world study in patients with chronic kidney disease..
Acta Gastroenterol Belg. 85(2), 331-337.
(2022).
Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know?.
Ann Hepatol. 19(2), 134-144.
(2020).
'Distribution of Hepatitis C Virus genotypes in northern Greece in the last decade: descriptive analysis and clinical correlations'..
Glob Health Epidemiol Genom. 4, e5.
(2019).
Performance of Baveno VI and Expanded Baveno VI Criteria for Excluding High-Risk Varices in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis..
Clin Gastroenterol Hepatol. 17(9), 1744-1755.e11.
(2019).
The significance of paired biopsies in estimating disease progression in patients with nonalcoholic steatohepatitis..
Eur J Gastroenterol Hepatol. 31(7), 897-898.
(2019).
Transarterial embolization for the treatment of complicated liver hemangiomas: A report of two cases and review of the literature..
Clin Mol Hepatol. 24(3), 345-349.
(2018).
Prevalence of hepatitis E in liver transplant recipients in Greece..
Epidemiol Infect. 146(13), 1619-1621.
(2018).
High serum ferritin is associated with worse outcome of patients with decompensated cirrhosis..
Ann Gastroenterol. 30(2), 217-224.
(2017).
Prognostic Models for Survival in Patients with Stable Cirrhosis: A Multicenter Cohort Study..
Dig Dis Sci. 62(5), 1363-1372.
(2017).
Treatment of chronic hepatitis C with direct-acting antivirals in patients with β-thalassaemia major and advanced liver disease..
Br J Haematol. 178(1), 130-136.
(2017).
Comparison of creatinine and cystatin formulae with Chromium-ethylenediaminetetraacetic acid glomerular filtration rate in patients with decompensated cirrhosis..
J Gastroenterol Hepatol. 32(1), 191-198.
(2017).
Nucleos(t)ide analogues for the prevention of hepatitis B recurrence after liver transplantation do not affect serum phosphorus levels..
Ann Gastroenterol. 29(2), 208-13.
(2016).
Treatment of alcoholic hepatitis: is this a "dead-end"?.
Ann Gastroenterol. 29(2), 236-7.
(2016).
Apparent Diffusion Coefficient Quantification in Determining the Histological Diagnosis of Malignant Liver Lesions..
J Cancer. 7(6), 730-5.
(2016).
Nucleos(t)ide analog(s) prophylaxis after hepatitis B immunoglobulin withdrawal against hepatitis B and D recurrence after liver transplantation..
Transpl Infect Dis. 18(5), 667-673.
(2016).
Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain..
Liver Transpl. 22(1), 132-3.
(2016).
Boceprevir for chronic HCV genotype 1 infection in treatment-experienced patients with severe fibrosis or cirrhosis: The Greek real-life experience..
Ann Gastroenterol. 28(4), 481-6.
(2015).
On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients..
Liver Int. 35(5), 1540-8.
(2015).
Telbivudine is associated with improvement of renal function in patients transplanted for HBV liver disease..
J Viral Hepat. 22(7), 574-80.
(2015).
The impact of newer nucleos(t)ide analogues on patients with hepatitis B decompensated cirrhosis..
Ann Gastroenterol. 28(1), 109-117.
(2015).
Value of 3 Tesla diffusion-weighted magnetic resonance imaging for assessing liver fibrosis..
Ann Gastroenterol. 28(1), 118-123.
(2015).
Antiviral therapy leads to histological improvement of HBeAg-negative chronic hepatitis B patients..
Ann Gastroenterol. 28(3), 374-378.
(2015).